Write a short note on Complications of Suxamethonium.
Overview
Despite its usefulness, suxamethonium has a wide range of adverse effects, some serious, which explains the search for alternatives (e.g. Rocuronium) for rapid sequence induction.
Key Complications
- Hyperkalaemia — a normal rise of ~0.5 mmol/L, but dangerous, potentially fatal in burns, major trauma/crush, spinal cord injury, denervation and prolonged immobility (up-regulated extrajunctional receptors) — can cause cardiac arrest.
- Malignant hyperthermia trigger.
- Bradycardia/arrhythmias (especially repeat doses, children) — prevent with atropine.
- Muscle pains (myalgia) from fasciculations. Raised intra-ocular, intracranial and intragastric pressure.
- Suxamethonium apnoea (cholinesterase deficiency).
- Anaphylaxis (one of the commoner anaesthetic triggers). Prolonged/repeated dosing → phase II block.
DANGER / REMEMBER
The most feared complication is fatal hyperkalaemic cardiac arrest in susceptible patients (burns after ~24–48 h, crush injury, spinal cord injury, denervating disease) — suxamethonium is contraindicated in these. It is also a malignant-hyperthermia trigger.
CLINICAL PEARL
Memory aid — suxamethonium’s hazards: hyperkalaemia, malignant hyperthermia, bradycardia, myalgia, raised pressures (IOP/ICP/gastric), apnoea (cholinesterase), anaphylaxis, and phase II block.
Alternatives & Context
The sheer breadth of these complications is the reason that, wherever its unique rapid-on/rapid-off profile is not essential, suxamethonium is avoided in favour of a non-depolarising agent, and why rocuronium with sugammadex reversal has increasingly replaced it even for rapid sequence induction. Where suxamethonium is still used, susceptible patients are identified in advance — those with burns, crush or spinal injuries, denervating neuromuscular disease or a family history of malignant hyperthermia or of prolonged apnoea — and an alternative is chosen for them, atropine is available for bradycardia, and the patient is warned about postoperative myalgia.
CLINICAL PEARL
Let the dangerous four lead your answer — hyperkalaemia (burns, crush, spinal injury, denervation), malignant hyperthermia, bradycardia and suxamethonium apnoea — then add myalgia, raised pressures and anaphylaxis.
Hyperkalaemic arrest in burns and denervation is the feared complication.
KEY POINT
Key points TO remember
- Hyperkalaemia (fatal in burns/crush/spinal injury/denervation) → contraindicated there.
- Malignant hyperthermia trigger; bradycardia (atropine); myalgia.
- Raises IOP/ICP/intragastric pressure; suxamethonium apnoea; anaphylaxis.
- Large/repeated doses → phase II block.
EXAM TIP
Sources: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.
All questions in Muscle Relaxants
- Q1Describe Neuromuscular Junction & Mechanism of Block in detail. ★
- Q2Describe Suxamethonium in detail. ★
- Q3Describe Non-depolarising Muscle Relaxants in detail. ★
- Q4Describe Reversal of Neuromuscular Blockade in detail. ★
- Q5Describe Monitoring Neuromuscular Blockade in detail. ★
- SN1Write a short note on Suxamethonium Apnoea. ★
- SN2Write a short note on Complications of Suxamethonium. ★
- SN3Describe Atracurium in detail.
- SN4Describe Sugammadex in detail.
- SN5Describe Neostigmine in detail.
- SN6Train-of-Four ★
- SN7Describe Rocuronium in detail.